
4
How much sooner the patented technology can detect cancer than current methods.
150,000
For early lung cancer detection.

Oncimmune leads the field in detecting cancer early. Its patented technology picks up the autoantibodies a body produces in response to cancer, which lets its tests find the disease as much as four years before current methods do.
More than 150,000 of its simple blood tests have been sold for finding lung cancer early, supplied to doctors whose patients have a lung spot or nodule.
To make early detection faster still, the company decided on an application helping doctors calculate quickly how likely it is that a patient has lung cancer.
The risk calculation had to be incorporated into a product and turned into something a doctor can use in a consultation.
The designs had to follow the brand book and then perform well on whatever the target audience actually carries.
The finished product had to be straightforward for doctors and their high-risk patients alike.

What we did
Oncimmune came to Netguru for the complete service — wireframes and screen design through to coding the mobile app — and a scoping session verified what the application actually needed to do.
React Native was proposed as the way to build this product efficiently across both platforms.
The first phase produced wireframes and interfaces letting a user calculate the probability of cancer in a handful of clicks.
Designs went into Zeplin so component styling could be verified quickly and precisely.
iOS and Android were developed simultaneously with performance checked across different devices as the work went.
01
Chosen to build the application efficiently for both platforms.
What’s next